Refocusing syphilis vaccine research on preventing vertical transmission
The Lancet Microbe · 2026-04 · 7 (4) · 101327
DOI: 10.1016/j.lanmic.2025.101327 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Microbe, 2026-04. Verfasst von Joseph D Tucker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC 27599, USA; MRC International Statistics & Epidemi…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bill & Melinda Gates Foundation.
Abstract (Originalsprache)
After decades of stagnation, syphilis vaccine development is beginning to gather momentum because of advances in understanding the outer membrane protein of Treponema pallidum, host–pathogen interactions, and the genomics of syphilis.1 Preventing vertical transmission of Treponema pallidum subsp pallidum (T pallidum) could be the most consequential target for a vaccine, given the substantial disability-adjusted life year (DALY) burden, profound adverse pregnancy outcomes, and global resurgence of congenital syphilis.
Autor:innen und Institutionen
- Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC 27599, USA; MRC International Statistics & Epidemiology Group, Department of Infectious Disease Epidemiology, London Sch…
- MRC International Statistics & Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK; The Health Research Unit Zimbabwe, Biomedical Researc…
- Department of Paediatrics and Child Health, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
- Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK.
- STD Institute, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China; Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Förderung
- Bill & Melinda Gates Foundation
Zitieren
APA
Tucker, J. D., Chikwari, C. D., Frigati, L., Grillová, L., & Zhou, P. (2026). Refocusing syphilis vaccine research on preventing vertical transmission. The Lancet Microbe, 7(4), 101327. https://doi.org/10.1016/j.lanmic.2025.101327
Vancouver
Tucker JD, Chikwari CD, Frigati L, Grillová L, Zhou P. Refocusing syphilis vaccine research on preventing vertical transmission. The Lancet Microbe. 2026;7(4):101327. doi:10.1016/j.lanmic.2025.101327
BibTeX
@article{Tucker2026,
author = {Tucker, Joseph D and Chikwari, Chido Dziva and Frigati, Lisa and Grillová, Linda and Zhou, Pingyu},
title = {Refocusing syphilis vaccine research on preventing vertical transmission},
journal = {The Lancet Microbe},
year = {2026},
volume = {7},
number = {4},
pages = {101327},
doi = {10.1016/j.lanmic.2025.101327}
}
EUVIMED